Correction to: Invest New Drugs (2013) 31:1265–1274
In the original publication of this article, the license subtype should be CC BY and not CC BY-NC.
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doi.org/10.1007/s10637-012-9910-y
Rights and permissions
About this article
Cite this article
Ito, T., Okusaka, T., Nishida, T. et al. Correction to: Phase II study of sunitinib in Japanese patients with unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumor. Invest New Drugs 37, 591 (2019). https://doi.org/10.1007/s10637-019-00757-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10637-019-00757-9